Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer

John O. Schorge, Neda M. Mahoney, David S. Miller, Robert L. Coleman, Carolyn Y. Muller, David M. Euhus, Gail E. Tomlinson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective. Ashkenazi women with double primary breast and ovarian cancer have a high prevalence (57%) of germline Jewish founder mutations in the BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT) genes. The purpose of this study was to determine the frequency and type of BRCA1-2 mutations in non-Ashkenazi families with at least one member having double primary breast and ovarian cancer. Methods. Women at increased risk for cancer based upon their family history were enrolled at the University of Texas Southwestern Familial Cancer Registry between 1992 and 2000. Blood samples from patients desiring genetic testing were sent for complete DNA sequencing of the BRCA1 and BRCA2 genes. Families with a member having both breast and ovarian cancer were identified and clinical data were obtained. Results. Sixty-two (7%) of 900 enrolled families were non-Ashkenazi and had at least one member with double primary breast and ovarian cancer. Twenty-one families had members who underwent genetic testing; 41 did not. Thirteen (62%) families had a germline BRCA1 (n = 11) or BRCA2 (n = 2) mutation; only one Jewish founder mutation (185delAG) was detected. Eight (38%) families tested negative. Six (86%) of seven women undergoing genetic testing who themselves had double primary breast and ovarian cancer were BRCA1-2 mutation carriers. Conclusions. Germline BRCA1-2 mutations are common in non-Ashkenazi families with a member having double primary breast and ovarian cancer. These mutations occurred throughout both genes, emphasizing the need for comprehensive sequencing. One family had the BRCA2 6985delCT mutation, which lies beyond the "ovarian cancer cluster" region,

Original languageEnglish (US)
Pages (from-to)383-387
Number of pages5
JournalGynecologic Oncology
Volume83
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Ovarian Neoplasms
Breast Neoplasms
Mutation
Genetic Testing
BRCA2 Gene
BRCA1 Gene
DNA Sequence Analysis
Registries
Neoplasms
Genes

Keywords

  • BRCA1-2 mutations
  • Breast cancer
  • Double primary malignancy
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Schorge, J. O., Mahoney, N. M., Miller, D. S., Coleman, R. L., Muller, C. Y., Euhus, D. M., & Tomlinson, G. E. (2001). Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. Gynecologic Oncology, 83(2), 383-387. https://doi.org/10.1006/gyno.2001.6431

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. / Schorge, John O.; Mahoney, Neda M.; Miller, David S.; Coleman, Robert L.; Muller, Carolyn Y.; Euhus, David M.; Tomlinson, Gail E.

In: Gynecologic Oncology, Vol. 83, No. 2, 2001, p. 383-387.

Research output: Contribution to journalArticle

Schorge, JO, Mahoney, NM, Miller, DS, Coleman, RL, Muller, CY, Euhus, DM & Tomlinson, GE 2001, 'Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer', Gynecologic Oncology, vol. 83, no. 2, pp. 383-387. https://doi.org/10.1006/gyno.2001.6431
Schorge, John O. ; Mahoney, Neda M. ; Miller, David S. ; Coleman, Robert L. ; Muller, Carolyn Y. ; Euhus, David M. ; Tomlinson, Gail E. / Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. In: Gynecologic Oncology. 2001 ; Vol. 83, No. 2. pp. 383-387.
@article{e0b461ebac7e4e91a63de4ce9b9b7bb7,
title = "Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer",
abstract = "Objective. Ashkenazi women with double primary breast and ovarian cancer have a high prevalence (57{\%}) of germline Jewish founder mutations in the BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT) genes. The purpose of this study was to determine the frequency and type of BRCA1-2 mutations in non-Ashkenazi families with at least one member having double primary breast and ovarian cancer. Methods. Women at increased risk for cancer based upon their family history were enrolled at the University of Texas Southwestern Familial Cancer Registry between 1992 and 2000. Blood samples from patients desiring genetic testing were sent for complete DNA sequencing of the BRCA1 and BRCA2 genes. Families with a member having both breast and ovarian cancer were identified and clinical data were obtained. Results. Sixty-two (7{\%}) of 900 enrolled families were non-Ashkenazi and had at least one member with double primary breast and ovarian cancer. Twenty-one families had members who underwent genetic testing; 41 did not. Thirteen (62{\%}) families had a germline BRCA1 (n = 11) or BRCA2 (n = 2) mutation; only one Jewish founder mutation (185delAG) was detected. Eight (38{\%}) families tested negative. Six (86{\%}) of seven women undergoing genetic testing who themselves had double primary breast and ovarian cancer were BRCA1-2 mutation carriers. Conclusions. Germline BRCA1-2 mutations are common in non-Ashkenazi families with a member having double primary breast and ovarian cancer. These mutations occurred throughout both genes, emphasizing the need for comprehensive sequencing. One family had the BRCA2 6985delCT mutation, which lies beyond the {"}ovarian cancer cluster{"} region,",
keywords = "BRCA1-2 mutations, Breast cancer, Double primary malignancy, Ovarian cancer",
author = "Schorge, {John O.} and Mahoney, {Neda M.} and Miller, {David S.} and Coleman, {Robert L.} and Muller, {Carolyn Y.} and Euhus, {David M.} and Tomlinson, {Gail E.}",
year = "2001",
doi = "10.1006/gyno.2001.6431",
language = "English (US)",
volume = "83",
pages = "383--387",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer

AU - Schorge, John O.

AU - Mahoney, Neda M.

AU - Miller, David S.

AU - Coleman, Robert L.

AU - Muller, Carolyn Y.

AU - Euhus, David M.

AU - Tomlinson, Gail E.

PY - 2001

Y1 - 2001

N2 - Objective. Ashkenazi women with double primary breast and ovarian cancer have a high prevalence (57%) of germline Jewish founder mutations in the BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT) genes. The purpose of this study was to determine the frequency and type of BRCA1-2 mutations in non-Ashkenazi families with at least one member having double primary breast and ovarian cancer. Methods. Women at increased risk for cancer based upon their family history were enrolled at the University of Texas Southwestern Familial Cancer Registry between 1992 and 2000. Blood samples from patients desiring genetic testing were sent for complete DNA sequencing of the BRCA1 and BRCA2 genes. Families with a member having both breast and ovarian cancer were identified and clinical data were obtained. Results. Sixty-two (7%) of 900 enrolled families were non-Ashkenazi and had at least one member with double primary breast and ovarian cancer. Twenty-one families had members who underwent genetic testing; 41 did not. Thirteen (62%) families had a germline BRCA1 (n = 11) or BRCA2 (n = 2) mutation; only one Jewish founder mutation (185delAG) was detected. Eight (38%) families tested negative. Six (86%) of seven women undergoing genetic testing who themselves had double primary breast and ovarian cancer were BRCA1-2 mutation carriers. Conclusions. Germline BRCA1-2 mutations are common in non-Ashkenazi families with a member having double primary breast and ovarian cancer. These mutations occurred throughout both genes, emphasizing the need for comprehensive sequencing. One family had the BRCA2 6985delCT mutation, which lies beyond the "ovarian cancer cluster" region,

AB - Objective. Ashkenazi women with double primary breast and ovarian cancer have a high prevalence (57%) of germline Jewish founder mutations in the BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT) genes. The purpose of this study was to determine the frequency and type of BRCA1-2 mutations in non-Ashkenazi families with at least one member having double primary breast and ovarian cancer. Methods. Women at increased risk for cancer based upon their family history were enrolled at the University of Texas Southwestern Familial Cancer Registry between 1992 and 2000. Blood samples from patients desiring genetic testing were sent for complete DNA sequencing of the BRCA1 and BRCA2 genes. Families with a member having both breast and ovarian cancer were identified and clinical data were obtained. Results. Sixty-two (7%) of 900 enrolled families were non-Ashkenazi and had at least one member with double primary breast and ovarian cancer. Twenty-one families had members who underwent genetic testing; 41 did not. Thirteen (62%) families had a germline BRCA1 (n = 11) or BRCA2 (n = 2) mutation; only one Jewish founder mutation (185delAG) was detected. Eight (38%) families tested negative. Six (86%) of seven women undergoing genetic testing who themselves had double primary breast and ovarian cancer were BRCA1-2 mutation carriers. Conclusions. Germline BRCA1-2 mutations are common in non-Ashkenazi families with a member having double primary breast and ovarian cancer. These mutations occurred throughout both genes, emphasizing the need for comprehensive sequencing. One family had the BRCA2 6985delCT mutation, which lies beyond the "ovarian cancer cluster" region,

KW - BRCA1-2 mutations

KW - Breast cancer

KW - Double primary malignancy

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=0034754914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034754914&partnerID=8YFLogxK

U2 - 10.1006/gyno.2001.6431

DO - 10.1006/gyno.2001.6431

M3 - Article

C2 - 11606101

AN - SCOPUS:0034754914

VL - 83

SP - 383

EP - 387

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -